Linda Spahiu
Corporate Officer/Principal bei KAROLINSKA DEVELOPMENT AB
Ursprung des Netzwerks ersten Grades von Linda Spahiu
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Financial Conglomerates | 12 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Linda Spahiu
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
AB INDUSTRIVÄRDEN | Financial Conglomerates | Corporate Officer/Principal | |
SINO BIOPHARMACEUTICAL LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal Chairman Corporate Officer/Principal | |
University of Toronto | College/University | Undergraduate Degree | |
Stockholm School of Economics | College/University | Masters Business Admin | |
University of Uppsala | College/University | Graduate Degree | |
Karolinska Development AB (Private Equity)
Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Investment Managers | Chief Executive Officer Director of Finance/CFO | |
SCIBASE HOLDING AB (PUBL) | Medical Specialties | Director/Board Member Director/Board Member | |
University of Stockholm | College/University | Undergraduate Degree | |
ATTANA AB | Medical/Nursing Services | Director/Board Member | |
University of Lund | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
University of the Witwatersrand | College/University | Graduate Degree | |
Deutsche Bank AG (Hong Kong)
Deutsche Bank AG (Hong Kong) Investment Banks/BrokersFinance Part of Deutsche Bank AG, Deutsche Bank AG (Hong Kong) is a financial institution that has been connecting worlds for 65 years. The company is based in Hong Kong, Hong Kong, and serves as the hub for corporate and commercial clients. The company's asset management division, DWS, is a market leader in Hong Kong with a broad product offering. Its corporate bank division is an established market leader in transaction banking, with a presence in 60 countries, including an extensive footprint in HK. The investment bank provides strategic advice to corporate and institutional clients, focusing on the bank’s traditional strengths in financing, advisory, fixed income, and currencies, together with a focused equity capital markets business. The private bank focuses on private customers across all segments as well as business clients, and in HK, this division is represented by a highly competitive wealth manager. The Chinese company was founded in 1958, and its CEO is Werner Steinmüller. | Investment Banks/Brokers | Corporate Officer/Principal | |
European Medical Device Industry Association | Director/Board Member | ||
Rhodes University | College/University | Undergraduate Degree | |
AIK FOTBOLL AB | Movies/Entertainment | Director of Finance/CFO | |
PROMIMIC AB | Medical Specialties | Corporate Officer/Principal Director/Board Member | |
Dilafor AB
Dilafor AB Pharmaceuticals: MajorHealth Technology Dilafor AB develops pharmaceutical products from heparin derivatives with low anticoagulant activity. It investigates document and exploits the pharmacological properties of derivatives in the field of obstetrics. The company was founded by Gunvor Ester Ekman-Ordeberg, Hans-Peter Ekre, Per-Olov Eriksson, Per Giléus, Kjell Gunnarsson, Erik Yngve Holmer, Göran Kvist, Ulf Lindahl, Anders Malmström, Tore Mellstrand, Johan Rasin, and Mats Wahlgren in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Pharmathen SA
Pharmathen SA Pharmaceuticals: MajorHealth Technology Pharmathen SA develops, manufactures, and markets pharmaceuticals. Its products include a-cnotren, adicanil, alcinin, atostana, aurid, azapin, belifax, calci-10, deprevix cr, esmocard, farbovil, faxiven, depilonine pro, depilonine cream, aripiprazole, atorvastatin, brinzolamide, caspofungin, and clopidogrel. The company was founded in 1969 and is headquartered in Pallini, Greece. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Pharmathen International SA
Pharmathen International SA Pharmaceuticals: MajorHealth Technology Pharmathen was founded in 1969 in Athens, as a private pharmaceutical company, and is focused on the development and marketing of pharmaceuticals, with a strong position in generics. With 3 state of the art research laboratories and 2 manufacturing units, Pharmathen is a completely vertically integrated company and its activities extend from the development of pharmaceutical products up to their distribution. The company's human resources works in the sectors of Research & Development (R&D), production and distribution of drugs to different countries worldwide. Now, Pharmathen's products are approved in all EU markets and distribution rights have been granted to the largest pharmaceutical companies in the world, particularly in Europe, the United States of America and Canada. | Pharmaceuticals: Major | Director/Board Member | |
S:t Eriks Ögonsjukhus AB
S:t Eriks Ögonsjukhus AB Hospital/Nursing ManagementHealth Services S:t Eriks Ögonsjukhus AB operates eye hospitals. It specializes in corneal transplant; medical and surgical treatments of retina; oculoplastic surgery, ophthalmic oncology and pathology services; and medical contact lens service for infants and children. The company is headquartered in Stockholm, Sweden. | Hospital/Nursing Management | Director/Board Member | |
DEDICARE AB | Other Consumer Services | Director/Board Member | |
Umecrine Cognition AB
Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Director/Board Member Director of Finance/CFO | |
Biomatcell AB
Biomatcell AB BiotechnologyHealth Technology Biomatcell AB operates as a holding company that commercializes inventions in the fields of biomaterial science and cell therapy by licensing its inventions and creating spin-off companies. It develops three-dimensional biomaterial scaffold geometries in bioactive ceramics and metals. It markets products and services based on research in the field of biomaterials and stem cells and patenting new ideas in the same area. The company was founded on May 11, 2004 and is headquartered in Gothenburg, Sweden. | Biotechnology | Director/Board Member | |
Swedish Standards Institute | Director/Board Member | ||
KDev Oncology AB
KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services KDev Oncology AB offers research and development of new cancer treatments. It provides know-how in the field of oncology. The company was founded by David Jern on July 14, 2005 and is headquartered in Solna, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
OSSDSIGN AB | Medical Specialties | Director/Board Member Director/Board Member | |
Stiftelsen Swecare | Director/Board Member | ||
Modus Therapeutics AB
Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Chief Executive Officer Director/Board Member | |
KD Incentive AB | Director/Board Member Director/Board Member | ||
MODUS THERAPEUTICS HOLDING AB | Biotechnology | Chairman Chief Executive Officer | |
Sjukvårdsleverantörernas Service AB | Chief Executive Officer | ||
Swedish Medtech Service AB
Swedish Medtech Service AB Miscellaneous Commercial ServicesCommercial Services Swedish Medtech Service AB is an association for medical technology in Sweden that brings together over 200 member companies to make Sweden the most attractive country for medical technology companies. The Swedish company's focus is on collaboration and they have a set of rules called "Samverkansreglerna". Anna Lefevre Skjöldbrand has been the CEO of the private company since 2005. | Miscellaneous Commercial Services | Chief Executive Officer | |
KDev Investments AB
KDev Investments AB BiotechnologyHealth Technology KDev Investments AB engages in research, sales, and development in the fields of medicine, biotechnology, pharmaceuticals, and medical technology. It also owns and manages investments of companies in the fields of medicine. Its portfolio will include both early and clinical stage pharmaceutical assets, as well as some technology assets. The company was founded on January 10, 2012 and is headquartered in Solna, Sweden. | Biotechnology | Chairman Director/Board Member | |
Scibase AB | Director/Board Member Director/Board Member | ||
Svenska Vaccinfabriken Produktion AB
Svenska Vaccinfabriken Produktion AB BiotechnologyHealth Technology Svenska Vaccinfabriken Produktion AB develops vaccines and immunotherapies to prevent and treat life-threatening diseases. The company is based in Stockholm, Sweden. The Swedish company was founded by Matti Sällberg, Margaret Chen, Jens Bäck, Lars Frelin. Richard Bethell has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Director/Board Member | |
Softhale NV
Softhale NV Miscellaneous Commercial ServicesCommercial Services Softhale NV engages in manufacturing medical, clinical and pharmaceutical equipment. The company was founded by Jurgen Rawert and Frank Bartels and is headquartered in Diepenbeek, Belgium. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
MedTech Europe | Director/Board Member | ||
Treadwell Therapeutics, Inc.
Treadwell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Treadwell Therapeutics, Inc. operates as a clinical-stage oncology firm. It develops small molecules designed to leverage world-class, innovative science in cancer biology and immune-oncology with pan-cancer potential, including hematological malignancies from the TIO Discovery development engine. The company was founded by Tak Wah Mak and Mark R. Bray in July 2019 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
PHion Therapeutics Ltd.
PHion Therapeutics Ltd. BiotechnologyHealth Technology PHion Therapeutics Ltd. operates as a therapeutic vaccine development company. Its vaccine program focuses on viral infections as it evokes a strong interferon gamma response. The firm's technology are RAVA and RAVA-V. The company was founded by Helen McCarthy in 2017 and is headquartered in Belfast, the United Kingdom. | Biotechnology | Director/Board Member | |
Sweden Medtech4health AB
Sweden Medtech4health AB Miscellaneous Commercial ServicesCommercial Services Sweden Medtech4health AB is a strategic innovation program for medical technology that serves as a national arena for research and innovation on artificial intelligence for medical image analysis. The private company is based in Stockholm, Sweden. The Swedish company aims to be a catalyst for more medical technology ideas in healthcare, an efficient healthcare provider, and a strengthened medical technology industry. | Miscellaneous Commercial Services | Chairman | |
COCIR | Director/Board Member | ||
E-Hälsomyndigheten | Director/Board Member | ||
Swecare Foundation | Director/Board Member | ||
AnaCardio AB
AnaCardio AB Pharmaceuticals: MajorHealth Technology AnaCardio AB is a clinical stage biopharmaceutical company based in Stockholm, Sweden. AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility to treat heart failure, a progressive cardiac syndrome affecting more than six million individuals in the US and nearly 100 million worldwide. The Swedish company's unique solution is based on the ghrelin signaling pathway, intended to increase contractility without causing adverse tachycardia, arrhythmia, ischemia, or hypotension. The company was founded by Lars Lund and is currently led by CEO Patrik Strömberg since 2021. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
invoX Pharma Ltd.
invoX Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., invoX Pharma Ltd. is a British biopharmaceutical company. The company is based in Kingston-upon-Thames, UK. The company was founded in 2021. Benjamin Toogood has been the CEO of the company since 2023. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chief Investment Officer | |
Rsq Capital
Rsq Capital Investment ManagersFinance Rsq Capital operates as a venture capital firm. The private company is based in Stockholm, Sweden. | Investment Managers | Private Equity Investor | |
Cure Cancer Foundation
Cure Cancer Foundation Miscellaneous Commercial ServicesCommercial Services Cure Cancer Foundation operates as a cancer care foundation. The private company is based in Austin, TX. | Miscellaneous Commercial Services | Director/Board Member |
Statistik
International
Schweden | 36 |
Belgien | 5 |
Südafrika | 3 |
Griechenland | 3 |
Vereinigte Staaten | 3 |
Sektoral
Health Technology | 19 |
Consumer Services | 10 |
Commercial Services | 7 |
Finance | 5 |
Health Services | 3 |
Operativ
Director/Board Member | 96 |
Corporate Officer/Principal | 22 |
Chairman | 12 |
Chief Executive Officer | 11 |
Independent Dir/Board Member | 9 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Linda Spahiu
- Unternehmensverbindungen